LEADER 02086nam0-2200577 --450 001 9910314860403321 005 20220510154412.0 010 $a978-88-214-4737-2$bpaperback 100 $a20190409d2018----kmuy0itay5050 ba 101 1 $aita$cita 102 $aIT 105 $aa 001yy 200 1 $aImmunologia cellulare e molecolare$fAbul K. Abbas, Andrew H. Lichtman, Shiv Pillai$ga cura di Silvano Sozzani$gcon la collaborazione di Francesco Annunziato ... [et al.]$gillustrazioni di David L. Baker, Alexandra Baker 205 $a9. ed- 210 $aMilano$cEdra$d2018 215 $aX, 577 p.$cill.$d28 cm 610 0 $aimmunologia cellulare e molecolare 610 0 $atumori 610 0 $aimmunità 610 0 $aallergie 676 $a616.079$v22$zita 700 1$aAbbas,$bAbul K.$079683 701 1$aLichtman,$bAndrew H.$079684 701 1$aPillai,$bShiv$0323427 702 1$aBaker,$bDavid L.$c 702 1$aBaker,$bAlexandra$f 702 1$aSozzani,$bSilvano 702 1$aAnnunziato,$bFrancesco$f<1968- > 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910314860403321 952 $a90 N 4a 19$b221/2019$fFMEBC 952 $a90 N 4a 20$b222/2019$fFMEBC 952 $a90 N 4a 21$b223/2019$fFMEBC 952 $a90 N 4a 22$b224/2019$fFMEBC 952 $a90 N 4a 23$b225/2019$fFMEBC 952 $a90 N 4a 24$b226/2019$fFMEBC 952 $a616.079-ABB-5$bINV. INT. 2021/1$cSC1 952 $a616.079-ABB-5A$bINV. INT. 2021/2$cSC1 952 $a616.079-ABB-5B$bINV. INT. 2021/3$cSC1 952 $a616.079-ABB-5C$bINV. INT. 2021/4$cSC1 952 $a616.079-ABB-5D$bINV. INT. 2021/5$cSC1 952 $a616.079-ABB-5E$bINV. INT. 2021/6$cSC1 952 $a616.079-ABB-5F$bINV. INT. 2021/7$cSC1 952 $a616.079-ABB-5G$bINV. INT. 2021/8$cSC1 952 $a616.079-ABB-5H$bINV. INT. 2021/9$cSC1 952 $a616.079-ABB-I$bINV. INT. 2021/10$cSC1 959 $aFMEBC 959 $aSC1 996 $aCellular and molecular immunology$916936 997 $aUNINA